These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36170835)

  • 1. FOXA1 regulates alternative splicing in prostate cancer.
    Del Giudice M; Foster JG; Peirone S; Rissone A; Caizzi L; Gaudino F; Parlato C; Anselmi F; Arkell R; Guarrera S; Oliviero S; Basso G; Rajan P; Cereda M
    Cell Rep; 2022 Sep; 40(13):111404. PubMed ID: 36170835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Nonsense-Mediated mRNA Decay Stimulation by Splicing Factor SRSF1.
    Aznarez I; Nomakuchi TT; Tetenbaum-Novatt J; Rahman MA; Fregoso O; Rees H; Krainer AR
    Cell Rep; 2018 May; 23(7):2186-2198. PubMed ID: 29768215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
    Krause WC; Shafi AA; Nakka M; Weigel NL
    Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pioneer transcription factors Foxa1 and Foxa2 regulate alternative RNA splicing during thymocyte positive selection.
    Lau CI; Rowell J; Yanez DC; Solanki A; Ross S; Ono M; Crompton T
    Development; 2021 Aug; 148(15):. PubMed ID: 34323272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells.
    Oh J; Pradella D; Shao C; Li H; Choi N; Ha J; Ruggiero S; Fu XD; Zheng X; Ghigna C; Shen H
    Cells; 2021 Apr; 10(4):. PubMed ID: 33918758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
    Hernández-Llodrà S; Segalés L; Safont A; Juanpere N; Lorenzo M; Fumadó L; Rodríguez-Vida A; Cecchini L; Bellmunt J; Lloreta-Trull J
    Prostate; 2019 Jul; 79(10):1156-1165. PubMed ID: 31090082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
    Parolia A; Cieslik M; Chu SC; Xiao L; Ouchi T; Zhang Y; Wang X; Vats P; Cao X; Pitchiaya S; Su F; Wang R; Feng FY; Wu YM; Lonigro RJ; Robinson DR; Chinnaiyan AM
    Nature; 2019 Jul; 571(7765):413-418. PubMed ID: 31243372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
    Jin HJ; Zhao JC; Wu L; Kim J; Yu J
    Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
    Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
    Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
    Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
    Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PRMT1-mediated SRSF1 methylation to suppress oncogenic exon inclusion events and breast tumorigenesis.
    Li WJ; Huang Y; Lin YA; Zhang BD; Li MY; Zou YQ; Hu GS; He YH; Yang JJ; Xie BL; Huang HH; Deng X; Liu W
    Cell Rep; 2023 Nov; 42(11):113385. PubMed ID: 37938975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.
    Imamura Y; Sakamoto S; Endo T; Utsumi T; Fuse M; Suyama T; Kawamura K; Imamoto T; Yano K; Uzawa K; Nihei N; Suzuki H; Mizokami A; Ueda T; Seki N; Tanzawa H; Ichikawa T
    PLoS One; 2012; 7(8):e42456. PubMed ID: 22879989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioneer of prostate cancer: past, present and the future of FOXA1.
    Teng M; Zhou S; Cai C; Lupien M; He HH
    Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.
    Chang HL; Lin JC
    Biochim Biophys Acta Mol Cell Res; 2019 Dec; 1866(12):118550. PubMed ID: 31491447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
    Guo W; Keener AL; Jing Y; Cai L; Ai J; Zhang J; Fisher AL; Fu G; Wang Z
    Prostate; 2015 Jun; 75(9):976-87. PubMed ID: 25808853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustion.
    Wahid M; Pratoomthai B; Egbuniwe IU; Evans HR; Babaei-Jadidi R; Amartey JO; Erdelyi V; Yacqub-Usman K; Jackson AM; Morris JC; Patel PM; Bates DO
    Cancer Immunol Immunother; 2023 Dec; 72(12):4001-4014. PubMed ID: 37973660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXA1: a transcription factor with parallel functions in development and cancer.
    Bernardo GM; Keri RA
    Biosci Rep; 2012 Apr; 32(2):113-30. PubMed ID: 22115363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.
    Gao S; Chen S; Han D; Wang Z; Li M; Han W; Besschetnova A; Liu M; Zhou F; Barrett D; Luong MP; Owiredu J; Liang Y; Ahmed M; Petricca J; Patalano S; Macoska JA; Corey E; Chen S; Balk SP; He HH; Cai C
    Nat Genet; 2020 Oct; 52(10):1011-1017. PubMed ID: 32868907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.
    Su Y; Zhang Y; Zhao J; Zhou W; Wang W; Han B; Wang X
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3225-3243. PubMed ID: 34258652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.